# Kansai Medical University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/kansai-medical-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 59.1 |
| Citations | 1,214,443 |
| City | Osaka |
| Country | JP |
| Description | Kansai Medical University is a research organisation in Osaka, JP. OpenAlex records 18,102 works and 1,214,443 citations for it. 4,151 researchers list it as their most recent affiliation. |
| Homepage | https://www.kmu.ac.jp |
| OpenAlex ID | https://openalex.org/I126884977 |
| Region | Osaka |
| Researchers | 4,151 |
| ROR ID | https://ror.org/001xjdh50 |
| Type | education |
| Works | 18,102 |

## University papers

Showing 12 of 106.

- [Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-in-metastatic-non-small-cell-lung-cancer/)
- [Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/osimertinib-in-untreated-i-egfr-i-mutated-advanced-non-small-cell-lung-cancer/)
- [Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC](https://scholariq.org/papers/overall-survival-with-osimertinib-in-untreated-i-egfr-i-mutated-advanced-nsclc/)
- [Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC](https://scholariq.org/papers/overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/)
- [Consensus statement on the pathology of IgG4-related disease](https://scholariq.org/papers/consensus-statement-on-the-pathology-of-igg4-related-disease/)
- [A cross-population atlas of genetic associations for 220 human phenotypes](https://scholariq.org/papers/a-cross-population-atlas-of-genetic-associations-for-220-human-phenotypes/)
- [Comprehensive genomic profiles of small cell lung cancer](https://scholariq.org/papers/comprehensive-genomic-profiles-of-small-cell-lung-cancer/)
- [Frequent pathway mutations of splicing machinery in myelodysplasia](https://scholariq.org/papers/frequent-pathway-mutations-of-splicing-machinery-in-myelodysplasia/)
- [Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011](https://scholariq.org/papers/comprehensive-diagnostic-criteria-for-igg4-related-disease-igg4-rd-2011/)
- [Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011](https://scholariq.org/papers/comprehensive-diagnostic-criteria-for-igg4-related-disease-igg4-rd-2011-2/)
- [International Consensus Diagnostic Criteria for Autoimmune Pancreatitis](https://scholariq.org/papers/international-consensus-diagnostic-criteria-for-autoimmune-pancreatitis/)
- [Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/updated-analysis-from-keynote-189-pembrolizumab-or-placebo-plus-pemetrexed-and/)

## University researchers

- [Kazuichi Okazaki](https://scholariq.org/researchers/kazuichi-okazaki/)
- [Kentaro Hayashida](https://scholariq.org/researchers/kentaro-hayashida/)
- [Hidefumi Kinoshita](https://scholariq.org/researchers/hidefumi-kinoshita/)
- [Takao Mishima](https://scholariq.org/researchers/takao-mishima/)
- [Kenta Takayasu](https://scholariq.org/researchers/kenta-takayasu/)

## University top topics

Showing 8 of 25.

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.